Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Quantitative evaluation of range and metabolic activity of hepatic alveolar echinococcosis lesion microenvironment using PET/CT and multi-site sampling method

Fig. 3

Lesion size, different clinical stages and previous medication history in each groups. a Lesion size in each groups (C > B, C > A, F > B, P < 0.05); b Different clinical stages in each groups (no apparent correlation or differences was observed between different clinical stages in different groups); c Previous medication history (albendazole) in each groups (except for Group A, no significance was observed between groups)

Back to article page